The health of lupus nephritis patients differs by race, a new study in Arthritis Care & Research suggests. Investigators analyzing a registry of end-stage renal disease (ESRD) patients found that outcomes for those with lupus nephritis varied by ethnicity.
Asians and Hispanics fared better than Caucasians, experiencing lower risks of mortality and cardiovascular events, such as heart attacks and strokes. African Americans, however, had worse health: both higher risks of cardiovascular events and mortality. Those under age 40 had even higher risks, compared to their Caucasian peers. African Americans were more likely to be hospitalized for heart failure and hemorrhagic stroke.
In an interview with Medical Research, lead researcher Jose Gomez-Puerta, MD, of Brigham and Women's Hospital in Boston, suggested that nephrologists closely monitor African American as well as Native American patients. Along with management of lupus nephritis, tight control of cardiovascular disease risk factors is warranted.
The health of lupus nephritis patients differs by race.
MedicalResearch: What is the background for this study? What are the main findings?
Dr. Gomez-Puerta: Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown etiology which can cause multiorgan system damage and which disproportionately affects women and non-Caucasian minorities. Up to 60% of SLE patients develop renal disease, lupus nephritis (LN), and of these, approximately one fifth progress to end-stage renal disease (ESRD). The risk of cardiovascular (CV) events and mortality is higher in patients with ESRD and in particular in patients suffering SLE. However, information about CV outcomes and mortality is limited in patients with LN associated ESRD.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.
From medicalresearch.com
